FDA OKs Relistor for opioid patients
User rating: 3 / 5 after 2 vote(s)
The U.S. Food and Drug Administration has approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients receiving opioids.
Full story »
|
The U.S. Food and Drug Administration has approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients receiving opioids.
|